Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wade Alan Reh
Targeting the High Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
Cancer Research
Cancer Research
Oncology
Related publications
Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition
Oncotarget
Oncology
Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome
Clinical Cancer Research
Cancer Research
Oncology
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin
Integrative Cancer Therapies
Oncology
Alternative Medicine
Complementary
Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin
Oncotarget
Oncology
High-Mobility Group Box 1 Protein (HMGB1) Neutralization Ameliorates Experimental Autoimmune Encephalomyelitis
Journal of Autoimmunity
Allergy
Immunology
Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy
Oncology Letters
Cancer Research
Oncology
ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells
International Journal of Oncology
Cancer Research
Oncology